Abacavir/lamivudine combination in the treatment of HIV: a review
Abacavir has been at the center of research and clinical interest in the last two years. The frequency of the associated abacavir hypersensitivity syndrome has decreased substantially since the introduction of routine testing for the HLA-B*5701 allele; the activity of the drug in HIV-infected person...
Saved in:
| Published in | Therapeutics and clinical risk management Vol. 6; no. default; pp. 83 - 94 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
New Zealand
Taylor & Francis Ltd
01.01.2010
Dove Press Dove Medical Press |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Abacavir has been at the center of research and clinical interest in the last two years. The frequency of the associated abacavir hypersensitivity syndrome has decreased substantially since the introduction of routine testing for the HLA-B*5701 allele; the activity of the drug in HIV-infected persons with HIV RNA values more than 100,000 copies/mL has been questioned; the possible increased risk of myocardial infarction after recent exposure to abacavir has been debated; and the drug has been moved from the "recommended" category to the "alternative" category in several guidelines. Still, the drug remains a useful agent in combination with other drugs, including lamivudine, for the treatment of HIV infection. This review will focus on the pharmacokinetics, activity, side effects, and resistance profile of both abacavir and lamivudine, including a thorough review of all of the recent studies relevant to both drugs. |
|---|---|
| AbstractList | Abacavir has been at the center of research and clinical interest in the last two years. The frequency of the associated abacavir hypersensitivity syndrome has decreased substantially since the introduction of routine testing for the HLA-B*5701 allele; the activity of the drug in HIV-infected persons with HIV RNA values more than 100,000 copies/mL has been questioned; the possible increased risk of myocardial infarction after recent exposure to abacavir has been debated; and the drug has been moved from the “recommended” category to the “alternative” category in several guidelines. Still, the drug remains a useful agent in combination with other drugs, including lamivudine, for the treatment of HIV infection. This review will focus on the pharmacokinetics, activity, side effects, and resistance profile of both abacavir and lamivudine, including a thorough review of all of the recent studies relevant to both drugs. Abacavir has been at the center of research and clinical interest in the last two years. The frequency of the associated abacavir hypersensitivity syndrome has decreased substantially since the introduction of routine testing for the HLA-B*5701 allele; the activity of the drug in HIV-infected persons with HIV RNA values more than 100,000 copies/mL has been questioned; the possible increased risk of myocardial infarction after recent exposure to abacavir has been debated; and the drug has been moved from the "recommended" category to the "alternative" category in several guidelines. Still, the drug remains a useful agent in combination with other drugs, including lamivudine, for the treatment of HIV infection. This review will focus on the pharmacokinetics, activity, side effects, and resistance profile of both abacavir and lamivudine, including a thorough review of all of the recent studies relevant to both drugs.Abacavir has been at the center of research and clinical interest in the last two years. The frequency of the associated abacavir hypersensitivity syndrome has decreased substantially since the introduction of routine testing for the HLA-B*5701 allele; the activity of the drug in HIV-infected persons with HIV RNA values more than 100,000 copies/mL has been questioned; the possible increased risk of myocardial infarction after recent exposure to abacavir has been debated; and the drug has been moved from the "recommended" category to the "alternative" category in several guidelines. Still, the drug remains a useful agent in combination with other drugs, including lamivudine, for the treatment of HIV infection. This review will focus on the pharmacokinetics, activity, side effects, and resistance profile of both abacavir and lamivudine, including a thorough review of all of the recent studies relevant to both drugs. Geetha Sivasubramanian1, Emmanuel Frempong-Manso2, Rodger D MacArthur11Division of Infectious Diseases, Wayne State University, Detroit, MI, USA; 2University of Pittsburgh Medical Center, Shadyside Hospital, Pittsburgh, OH, USAAbstract: Abacavir has been at the center of research and clinical interest in the last two years. The frequency of the associated abacavir hypersensitivity syndrome has decreased substantially since the introduction of routine testing for the HLA-B*5701 allele; the activity of the drug in HIV-infected persons with HIV RNA values more than 100,000 copies/mL has been questioned; the possible increased risk of myocardial infarction after recent exposure to abacavir has been debated; and the drug has been moved from the “recommended” category to the “alternative” category in several guidelines. Still, the drug remains a useful agent in combination with other drugs, including lamivudine, for the treatment of HIV infection. This review will focus on the pharmacokinetics, activity, side effects, and resistance profile of both abacavir and lamivudine, including a thorough review of all of the recent studies relevant to both drugs.Keywords: HIV, abacavir, lamivudine |
| Author | MacArthur, Rodger |
| AuthorAffiliation | 1 Division of Infectious Diseases, Wayne State University, Detroit, MI, USA 2 University of Pittsburgh Medical Center, Shadyside Hospital, Pittsburgh, OH, USA |
| AuthorAffiliation_xml | – name: 2 University of Pittsburgh Medical Center, Shadyside Hospital, Pittsburgh, OH, USA – name: 1 Division of Infectious Diseases, Wayne State University, Detroit, MI, USA |
| Author_xml | – sequence: 1 givenname: Rodger surname: MacArthur fullname: MacArthur, Rodger |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20234788$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdUl1rFDEUDVKxH_riD5ABHwRhu_mcJD4Iy6J2oSJoFd9CJnOnzTKTrMnMiv_ebLdb2uYll5uTc8-995yioxADIPSa4HNKuJxfLb9_Pf9BaiGfoRNCpJpRzH4fPYiP0WnOa4x5rTV5gY4ppoxLpU7QYtFYZ7c-zXs7-O3U-gCVi0Pjgx19DJUP1XgD1ZjAjgOEsYpddbH69aGyVYKth78v0fPO9hle3d1n6OfnT1fLi9nlty-r5eJy5rjE4wxYS4ilrKHK7lRI7bRmggmpBCOcs4Z3HXSKN7XllvKaihZTIUBKELqV7Ayt9rxttGuzSX6w6Z-J1pvbREzXxqbRux4McBBOOKeVoFwXwhLXLWbKNpQxqQrXxz3XZmoGaF3pK9n-Eenjl-BvzHXcGqqYEDUrBPODmC1sEuT8RNEhW0ZpOMZ1-fHurmSKfybIoxl8dtD3NkCcspFFGJFc6oJ8-wS5jlMKZbaGlqPL6igpqDcPW7gvf1htAbzfA1yKOSfo7iEEm51vzM435tY37D94srPv |
| ContentType | Journal Article |
| Copyright | 2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2010 Sivasubramanian et al, publisher and licensee Dove Medical Press Ltd. |
| Copyright_xml | – notice: 2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2010 Sivasubramanian et al, publisher and licensee Dove Medical Press Ltd. |
| DBID | AAYXX CITATION NPM 3V. 7RV 7X7 7XB 88C 8AO 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. KB0 M0S M0T M2O MBDVC NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.2147/TCRM.S1657 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni) Healthcare Administration Database ProQuest Research Library Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1178-203X |
| EndPage | 94 |
| ExternalDocumentID | oai_doaj_org_article_e4e5c5cc985249b6a5cc6d038ab23378 PMC2835563 oai_dovepress_com_4006 20234788 10_2147_TCRM_S1657 |
| Genre | Journal Article |
| GroupedDBID | --- 0YH 123 29Q 2WC 53G 5VS 6PF 7RV 7X7 8AO 8FI 8FJ 8G5 AAWTL AAYXX ABDBF ABUWG ACGFO ACUHS ADBBV ADRAZ AENEX AFKRA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AQUVI AZQEC BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI CCPQU CITATION CS3 DIK DWQXO E3Z EBD EBS EJD ESX F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR IHW ITC KQ8 M0T M2O M48 NAPCQ O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM TDBHL TR2 TUS UKHRP VDV NPM 3V. 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 - ABPTK ADACO BBAFP LI0 M~E 5PM PUEGO |
| ID | FETCH-LOGICAL-c470t-e3d11a23b28a699179c99353578531443b4ffef84b6a4a24625d0255e77e59d73 |
| IEDL.DBID | M48 |
| ISSN | 1178-203X 1176-6336 |
| IngestDate | Wed Aug 27 01:29:58 EDT 2025 Thu Aug 21 18:19:59 EDT 2025 Mon Jan 18 10:57:33 EST 2021 Fri Jul 11 00:08:59 EDT 2025 Fri Jul 25 07:27:54 EDT 2025 Thu Apr 03 07:02:01 EDT 2025 Tue Jul 01 02:36:36 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | default |
| Keywords | HIV abacavir lamivudine |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c470t-e3d11a23b28a699179c99353578531443b4ffef84b6a4a24625d0255e77e59d73 |
| Notes | ObjectType-Article-1 ObjectType-Evidence Based Healthcare-3 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2222923421?pq-origsite=%requestingapplication% |
| PMID | 20234788 |
| PQID | 2222923421 |
| PQPubID | 3933272 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_e4e5c5cc985249b6a5cc6d038ab23378 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2835563 dovepress_primary_oai_dovepress_com_4006 proquest_miscellaneous_733717479 proquest_journals_2222923421 pubmed_primary_20234788 crossref_primary_10_2147_TCRM_S1657 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-01-01 |
| PublicationDateYYYYMMDD | 2010-01-01 |
| PublicationDate_xml | – month: 01 year: 2010 text: 2010-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | New Zealand |
| PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
| PublicationTitle | Therapeutics and clinical risk management |
| PublicationTitleAlternate | Ther Clin Risk Manag |
| PublicationYear | 2010 |
| Publisher | Taylor & Francis Ltd Dove Press Dove Medical Press |
| Publisher_xml | – name: Taylor & Francis Ltd – name: Dove Press – name: Dove Medical Press |
| SSID | ssj0046991 |
| Score | 1.8783672 |
| SecondaryResourceType | review_article |
| Snippet | Abacavir has been at the center of research and clinical interest in the last two years. The frequency of the associated abacavir hypersensitivity syndrome has... Geetha Sivasubramanian1, Emmanuel Frempong-Manso2, Rodger D MacArthur11Division of Infectious Diseases, Wayne State University, Detroit, MI, USA; 2University... |
| SourceID | doaj pubmedcentral dovepress proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 83 |
| SubjectTerms | abacavir Antiretroviral drugs Evidence-based medicine HIV Human immunodeficiency virus lamivudine Review |
| SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hXoADgvIKFGQJVHFo2PU74bZUrRakogq2qDfLdhyxlyzqPqT-e8b2brpbVeLSWxRHifWNnZnPHn8D8JFR77yrkKa21JeCe1o6Ltsy1LVn1A6Dt3Ed8uyHGl-I75fycqvUV8wJy_LAGbhBEEF66X1dSWQKTlm8Vs2QV9YxznU65os-b0Om8j8YOV-qlUepVqXicYMyCpPGmjyDyfHPs8-_qIoOacsVJcX-x_Cwma1yCupdIeftzMktV3T6FJ6sY0gyyn1_Bg9Ctw-H51mE-vqITG7OVM2PyCE5v5Gnvn4Oo5Gz3q6mVwMcDNPVEp1XIDjukCInK5FpRzAqJH0KOpm1ZPzt9xdiST7o8gIuTk8mx-NyXUih9EIPF2XgDaWWcccqG5HRtcewRCahG46MijvRtqGtBMIrLBPIiZrINYLWQdaN5i9hr5t14TUQXbX4lKOWOoz1hLCUtTx4ySxvVLBVAR82mJq_WS_DIM-IyJuIvEnIF_A1wt0_ETWu0w20vFlb3vzP8gV86o11602buwiewZ-UKuBgY0uznqNzw2Ipc8YFowWQvhlnV9wysV2YLedG44eQs-m6gFfZ8v2XYt35WHugAL0zJna6stvSTf8kAe-ocScVf3MfKLyFRzmhIa4KHcDe4moZ3mGctHDv05T4B8jFEWY priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BOQCHimcJFGQJVHFo2PUjccIFLRXVglRUwRbtzbIdB_aSlH1J_fedSbLZboW4RbYVWzN-zDcefwPwTnDvvMsQppbcx0p6HjuZlHHIcy-4HQZvyQ959j0dX6hv02TaOdwWXVjlZk9sNuqi9uQjHwhKPC2kEvzT5d-YskbR7WqXQuMu3CPqMgrp0tMecCHyazLmca7TOJV0TUn0pJSZZzA5-XH24SdP6Vi6cSA1vP0P4X5Rr9tA1H8ZnrfjJ28cSKePYL-zJNmoVf1juBOqJ3B03lJRXx2zyfZl1eKYHbHzLUn11VMYjZz1dj2bD3BKzNYrPMICQ0kgUG50xWYVQ9uQ9YHorC7Z-Ouvj8yy9rnLM7g4_TI5GcddOoXYKz1cxkEWnFshncgsSUbnHo2TpKG7kYirpFNlGcpMudQqKxQio4IQR9A6JHmh5XPYq-oqvACmsxJbOW65Q4tPKctFKYNPhJVFGmwWwduNTM1ly5phEG2Q5A1J3jSSj-AzibtvQUzXTUE9_226hWOCColPvM-zBJEiDg2_02IoM-uElBq7et8r69afNqUoPINbVRrB4UaXplupC7OdVxGwvhrXGF2c2CrUq4XR2BEiN51HcNBqvu-Jss9TBoII9M6c2BnKbk01-9PQeBPTXZLKl_8f1St40AYskNfnEPaW81V4jXbQ0r1pJvs1Y4YIqQ priority: 102 providerName: ProQuest |
| Title | Abacavir/lamivudine combination in the treatment of HIV: a review |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/20234788 https://www.proquest.com/docview/2222923421 https://www.proquest.com/docview/733717479 http://www.dovepress.com/getfile.php?fileID=5814 https://pubmed.ncbi.nlm.nih.gov/PMC2835563 https://doaj.org/article/e4e5c5cc985249b6a5cc6d038ab23378 |
| Volume | 6 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwED_t4wH2gPjcAqOyBJp4WLb6I3GChFA3bSpInarRor5ZtuNAJUigX6L_PeekzWg1ibfIcWLrfGffzz7_DuAto9ZYkyBMzakNBbc0NDzKQ5emllHddlb7fcjeTdwdis-jaLQD6_ydKwFO74V2Pp_UcPLj7M_v5Uc0-A8-jJkKeY5T1s-zKY0juQv7uCJJb6A90ZwmIAKsMudRKr1W8FFNU7r17cbCVPH3H8CDrFzUAan3OaDbcZT_LEzXj-HRyqMknVoFnsCOK57CSb-mpF6eksHdDavpKTkh_Tuy6uUz6HSMtnoxnpyjaowXc1zKHEEtRMBcjRkZFwR9RNIEpJMyJ91PX98TTeprL89heH01uOyGq7QKoRWyPQsdzyjVjBuWaC8ZmVp0UqKK9oYjvuJG5LnLE2FiLTQTiJAyjzyclC5KM8lfwF5RFu4IiExyrGWopgY9PyE0ZTl3NmKaZ7HTSQBv1jJVv2r2DIWow0teDS5ve-qLl3wAF17cTQ3PeF0VlJNvamVAygkX2cjaNIkQMWLX8DnO2jzRhnEusal3zWBt_WldisJTOGXFARyvx1KtFU4xn9icccFoAKR5jbbmD1B04cr5VElsCBGcTAM4rEe-aclnofeZCAKQGzqx0ZXNN8X4e0Xn7Rnvopi__H-zr-BhHbzgd4COYW82mbvX6BPNTAt25Ui2YP_i6qZ_26p2FlqVEfwFKFQRVg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6V9FA4IN4sFLAEVBy6JH7sCwmhtLRKaBNFJUW9GdvrhVx2S14of4rfyHg3mzQV4tbbandlW-PxzHz2eD6AN4wabXSMMDWjxhfcUF_zIPNtkhhGVcsa5fYhe_2wcy6-XAQXW_Cnvgvj0iprm1ga6rQwbo-8yRzxNOOC0U-Xv3zHGuVOV2sKjUotTuziN0K2ycfuZ5zft4wdHw0PO_6SVcA3ImpNfctTShXjmsUqxOgoSgz66KCs-sIRXnAtssxmsdChEooJBAipC7xtFNkgSSOO7d6CbcERyjRg--CoPzirbb9wDVZ0LqEfcncw6gqiOi6g5vDwrPf-Kw2dI7ziAkumgDuwkxbzKvX1X6Hu9YzNKy7w-B7cXcaupF0p233YsvkD2BtUxa8X-2S4vss12Sd7ZLAui714CO22VkbNR-MmKuFoPkOnaQnKHqF5qR1klBOMRskq9Z0UGel0v30gilQXbB7B-Y2I-jE08iK3T4FEcYZ_aaqoxhhTCEVZxq0JmOJpaFXswetapvKyqtMhEd84yUsneVlK3oMDJ-7VH662dvmiGP-Qy6UqrbCBCYxJ4gCxKQ4Nn8O0xWOlGecRdvVuNVnXWqrfovAkGsfQg916LuXSNkzkWpM9IKvPuKrdUY3KbTGbyAg7QqwYJR48qWZ-1ZPju3ecBx5EGzqxMZTNL_noZ1k43NXWC0L-7P-jegU7nWHvVJ52-yfP4XaVLuH2nHahMR3P7AuMwqb65VL1CXy_6dX2F_oPRJw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIcF4QHwvMMASMPGw0PojcYKEUNmoWsamCjrUN-M4DvQlGf1C_df46zgnTbpOiLe9RY5lW_fhu599vgN4yahJTBIhTM2o8QU31E94kPk2jg2jum2NdueQJ6dh70x8GgWjLfhTv4VxYZX1nlhu1Glh3Bl5i7nC04wLRlvZKixicNR9f_7LdxWk3E1rXU6jEpFju_yN8G36rn-EvH7FWPfj8LDnryoM-EbI9sy3PKVUM56wSIfoKcnYoL0OygwwHKEGT0SW2SwSSaiFZgLBQuqccCulDeJUchz3GlyXPKBOx-SoAXvCDVcVdgn9kLsrUpca1VUFag0Pv5y8-UpDZxIvGMOyZsAtuJkWiyoI9l9O7-XYzQvGsHsHbq-8WNKpxO4ubNn8HuwPqjTYywMyXL_qmh6QfTJYJ8he3odOJ9FGL8aTForjeDFH82kJcgFBeiknZJwT9EtJEwRPioz0-t_eEk2qpzYP4OxKCP0QtvMit7tAZJRhr4RqmqC3KYSmLOPWBEzzNLQ68uBFTVN1XmXsUIh0HOWVo7wqKe_BB0fupofLsl02FJMfaqW0ygobmMCYOAoQpeLS8DtM2zzSCeNc4lSvG2ZdGqluReIp3CZDD_ZqXqrVLjFVa5n2gDS_Ub_dpY3ObTGfKokTIWqUsQePKs43MzH0t1z1Aw_khkxsLGXzTz7-WaYQd1n2gpA__v-qnsMN1DH1uX96_AR2qrgJd_i0B9uzydw-RXdsljwr5Z7A96tWtL-E5Uds |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abacavir%2Flamivudine+combination+in+the+treatment+of+HIV%3A+a+review&rft.jtitle=Therapeutics+and+clinical+risk+management&rft.au=Sivasubramanian%2C+Geetha&rft.au=Frempong-Manso%2C+Emmanuel&rft.au=Macarthur%2C+Rodger+D&rft.date=2010-01-01&rft.issn=1178-203X&rft.eissn=1178-203X&rft.volume=6&rft.spage=83&rft_id=info:doi/10.2147%2Ftcrm.s1657&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-203X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-203X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-203X&client=summon |